Axon price target raised to $240 from $200 at Needham

Needham analyst Joshua Reilly raised the firm’s price target on Axon to $240 from $200 and keeps a Buy rating on the shares. The analyst notes the company’s release of a new version of TASER – TASER 10 – which is expected to be broadly adopted by law enforcement globally as the new features and functionality are "significantly advanced" from TASER 7. More details on pricing and launch date will likely follow the Q4 earnings call, which is expected in mid-February, Needham adds.